Summary
- Current Price
- As of today, HLN price is $9.58, down -2.24% on
- Current Price All-Time High
- HLN price is currently -16.11% below its historical high of $11.42 set on
- Market Cap
- HLN current market cap is $42B, down -5.92% year-over-year
- Revenue
- HLN current annual revenue is $14.54B, up +1.27% year-over-year
- Next Earnings
- The next earnings release for HLN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Haleon plc |
| Ticker | NYSE: HLN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | haleon.com |
| Employees | 24,561 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $9.58 | |
| Price, 1D Change | -2.24% | |
| Market Cap | $42B | |
| TTM Dividend Yield | 2.03% | |
| PE Ratio | - | |
| Beta | -0.07 | |
| Revenue | $14.54B | |
| Revenue, 1Y Change | +1.27% | |
| EPS | $0.49 | |
| EPS, 1Y Change | +21.18% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.06 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | HLN.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $0.49 | |
| EPS Estimate | - | |
| EPS Est. Change | - | |
| Revenue | $14.54B | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $9.58 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.28 | - | |
| - | $0.40 | - | |
| - | $0.49 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $14.05B | - | |
| - | $14.35B | - | |
| - | $14.54B | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -1.24% | |
| Price, 3Y | +10.37% | |
| Market Cap, 1Y | -5.92% | |
| Market Cap, 3Y | +5.14% | |
| Revenue, 1Y | +1.27% | |
| Revenue, 3Y | +8.69% | |
| EPS, 1Y | +21.18% | |
| EPS, 3Y | +72.14% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $9.58 | |
| SMA 200 | $9.81 | |
| SMA 50 | $9.58 | |
| EMA 200 | $9.72 | |
| EMA 50 | $9.70 | |
| MACD | $0.02 | |
| Beta | -0.07 | |
| ATR | $0.19 | |
| 14-Day RSI | 41.93 | |
| 10-Day Volatility | 15.56% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.06 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.92% | |
| Total Dividend | $0.18 | |
| $806.55M | ||
| 36.43% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $14.54B | |
| EPS | $0.49 | |
| Gross Profit | $9.42B | |
| Gross Margin | 64.77% | |
| Operating Income | $3.26B | |
| Operating Margin | 22.44% | |
| Net Income | $2.21B | |
| Net Margin | 15.23% | |
| EBITDA | $3.74B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.52 | |
| 0.92 | ||
| 0.71 | ||
| - | ||
| - | ||
| 2.92 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 1.93 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $22.09B | |
| $1.78B | ||
| $43.89B | ||
| $6.12B | ||
| $21.72B | ||
| $6.64B | ||
| Total Debt | $11.58B | |
| $1.12B | ||
| $5.02B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $12.34B | ||
| $6.15B | ||
| $5.12B | ||
| $0.00 | ||
| $474.44M | ||
| $0.00 | ||
| $622.04M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $3.08B | ||
| -$764.38M | ||
| -$3.44B | ||
| Capex | $544.29M | |
| $2.54B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| Argus Research | → | |
| Morgan Stanley | ||
| Argus Research | → | |
| Argus Research | ||
| Deutsche Bank |
Analyst sentiment
Institutional ownership
Screeners with HLN
FAQ
- What is the ticker symbol for Haleon plc?
- The ticker symbol for Haleon plc is NYSE:HLN
- Does Haleon plc pay dividends?
- Yes, Haleon plc pays dividends. The last payment was $0.06, with an ex-dividend date on August 14, 2026
- What sector is Haleon plc in?
- Haleon plc is in the Healthcare sector
- What industry is Haleon plc in?
- Haleon plc is in the Specialty & Generic Drug Manufacturers industry
- What country is Haleon plc based in?
- Haleon plc is headquartered in United Kingdom
- When did Haleon plc go public?
- Haleon plc initial public offering (IPO) was on July 25, 2022
- Is Haleon plc in the S&P 500?
- No, Haleon plc is not included in the S&P 500 index
- Is Haleon plc in the NASDAQ 100?
- No, Haleon plc is not included in the NASDAQ 100 index
- Is Haleon plc in the Dow Jones?
- No, Haleon plc is not included in the Dow Jones index
- When was Haleon plc last earnings report?
- Haleon plc's most recent earnings report was on July 30, 2026
- When does Haleon plc report earnings?
- The next expected earnings date for Haleon plc is February 24, 2027
Data Sources & References
- HLN Official Website www.haleon.com
- HLN Profile on Yahoo Finance finance.yahoo.com/quote/HLN
- HLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hln